Research Summary
Analyzed using Evidence Intelligence™

Cinnamomum zeylanicum improves glycemic control in type 2 diabetes

Key finding

Reduction in fasting blood glucose levels in the cinnamon group was found -35.50% (95% CI, -173 to 58.4).

This study evaluated the effects of Cinnamomum zeylanicum on glycemic control in individuals with type 2 diabetes, finding significant reductions in fasting plasma glucose levels.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Some Concerns bias
Last updated July 6, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Cinnamomum zeylanicum, Placebo

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Primary outcome

Fasting Plasma Glucose (FPG)

Comparator

Placebo Group

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

This study evaluated the effects of Cinnamomum zeylanicum on glycemic control in individuals with type 2 diabetes, finding significant reductions in fasting plasma glucose levels.

Clinical relevance

Effective management of blood sugar levels is crucial for individuals with type 2 diabetes to prevent complications. The significant reduction in fasting plasma glucose levels observed with Cinnamomum zeylanicum indicates its potential as a complementary treatment option, which could improve patient outcomes and enhance glycemic control strategies.

Keep in mind

The study's sample size may limit the generalizability of the findings. The duration of the intervention was not specified, which could affect long-term outcomes. Potential confounding factors were not fully addressed.

Published in

Journal Reference

Publication details and source links for this paper.

Alexander M, John RA, Anindita M, et al. Effects of Cinnamomum zeylanicum on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial. Cureus. 2023;15(2):e35023. doi:10.7759/cureus.35023

Save this study and add notes to your research library.

Main Effects

Cinnamomum zeylanicum reduced fasting plasma glucose by 35.5% (p=0.001).

Glycosylated hemoglobin (HbA1c) decreased by 0.85% in the cinnamon group (p=0.039).

Significant inhibition of PTP1B expression was observed (p=0.039).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Cinnamomum zeylanicum and Fasting Plasma Glucose (FPG), HbA1c, PTP1B expression.

Primary intervention

Cinnamomum zeylanicum

Primary outcomes

  • Fasting Plasma Glucose (FPG)
  • HbA1c
  • PTP1B expression

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

3
Evidence pairs
3
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 64

2

Related topics

3

Evidence pairs

270

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 3 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

StrongDecrease

Fasting Plasma Glucose (FPG)

Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)

Cinnamomum zeylanicum → Fasting Plasma Glucose (FPG)

Evidence profile

StrongDecreaseGlycemic Control
Unlock full evidence details
StrongDecrease

HbA1c

Cinnamomum zeylanicum → HbA1c

Cinnamomum zeylanicum → HbA1c

Evidence profile

StrongDecreaseGlycemic Control
Unlock full evidence details
StrongDecrease

PTP1B expression

Cinnamomum zeylanicum → PTP1B expression

Cinnamomum zeylanicum → PTP1B expression

Evidence profile

StrongDecreaseMetabolic Health
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • Cinnamomum zeylanicum led to a 35.5% decrease in fasting plasma glucose.
  • A 0.85% reduction in HbA1c was noted with cinnamon treatment.
  • PTP1B expression was significantly inhibited, indicating a possible mechanism.
who this applies

Who this applies to

  • Adults diagnosed with type 2 diabetes.
  • Individuals seeking alternative treatments for glycemic control.
keep in mind

Keep in Mind

  • Results may not apply to populations outside the study's demographic.
  • Further research is needed to confirm long-term effects and safety.
  • The study did not include a diverse range of participants, which may affect applicability.
between the lines

Between the Lines

  • The study's sample size may limit the generalizability of the findings.
  • The duration of the intervention was not specified, which could affect long-term outcomes.
  • Potential confounding factors were not fully addressed.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Cinnamomum zeylanicum and Fasting Glucose, Cinnamomum zeylanicum and HbA1c.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Cinnamomum zeylanicum improve fasting plasma glucose (fpg)?

Emerging Evidence

Cinnamomum zeylanicum appears to improve Fasting Plasma Glucose (FPG).

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Cinnamomum zeylanicum improve HbA1c?

Emerging Evidence

Cinnamomum zeylanicum appears to improve HbA1c.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Cinnamomum zeylanicum improve ptp1b expression?

Emerging Evidence

Cinnamomum zeylanicum appears to improve PTP1B expression.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    PTP1B expression

    EvidenceScore™ Emerging | EvidenceScore™ 51.7 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.